Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis

by Harpreet K. Lota, Elisabetta A. Renzoni
Published 2012-01-01

Telomeres in Interstitial Lung Disease

by Carmel J. W. Stock, Elisabetta A. Renzoni
Published 2021-03-01

Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns

by Yet H. Khor, Elisabetta A. Renzoni, Dina Visca, Christine F. McDonald, Nicole S. L. Goh
Published 2019-09-01

Cough in idiopathic pulmonary fibrosis

by Mirjam J.G. van Manen, Surinder S. Birring, Carlo Vancheri, Vincent Cottin, Elisabetta A. Renzoni, Anne-Marie Russell, Marlies S. Wijsenbeek
Published 2016-09-01

Bromodomain and Extraterminal (BET) Protein Inhibition Restores Redox Balance and Inhibits Myofibroblast Activation

by Carmel J. W. Stock, Charalambos Michaeloudes, Patricia Leoni, Andrew L. Durham, Sharon Mumby, Athol U. Wells, Kian Fan Chung, Ian M. Adcock, Elisabetta A. Renzoni, Gisela E. Lindahl
Published 2019-01-01

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial

by Peter Saunders, Vicky Tsipouri, Gregory J. Keir, Deborah Ashby, Marcus D. Flather, Helen Parfrey, Daphne Babalis, Elisabetta A. Renzoni, Christopher P. Denton, Athol U. Wells, Toby M. Maher
Published 2017-06-01

Research highlights from the 2018 ERS International Congress: interstitial lung diseases

by Tiago M. Alfaro, Catharina C. Moor, Veronica Alfieri, Florence Jeny, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2019-02-01

ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly

by Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M. Alfaro, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2020-10-01

Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study

by William D-C Man, Matthew Maddocks, Toby M Maher, Athol U Wells, Elisabetta A Renzoni, Suhani Patel, Jessica A Walsh, Felix Chua, Philip L Molyneaux, Peter M George, Ruth E Barker, Claire M Nolan, Oliver Polgar, Vasilis Kouranos
Published 2021-06-01

Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial

by Dina Visca, Vicky Tsipouri, Letizia Mori, Ashi Firouzi, Sharon Fleming, Morag Farquhar, Elizabeth Leung, Toby M. Maher, Paul Cullinan, Nick Hopkinson, Athol U. Wells, Winston Banya, Jennifer A. Whitty, Huzaifa Adamali, Lisa G. Spencer, Piersante Sestini, Elisabetta A. Renzoni
Published 2017-04-01

Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes

by Nynke A. Kampstra, Paul B. van der Nat, Lea M. Dijksman, Frouke T. van Beek, Daniel A. Culver, Robert P. Baughman, Elisabetta A. Renzoni, Wim Wuyts, Vasilis Kouranos, Pieter Zanen, Marlies S. Wijsenbeek, Marinus J.C. Eijkemans, Douwe H. Biesma, Philip J. van der Wees, Jan C. Grutters
Published 2019-10-01